Brunn Carsten bought RNAC
January 2, 2026 · Form 4 insider transaction
Brunn Carsten bought 415,700 shares of Cartesian Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
415,700
Price
$0.00
Total value
N/A
InsiderBrunn Carsten
Role—
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2026
Filing dateJanuary 6, 2026
Shares owned after415,700
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option vests as to 25% on January 2, 2027. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter.